Slc35a2 Gene Summary [Rat]

Predicted to enable UDP-galactose transmembrane transporter activity. Predicted to be involved in UDP-galactose transmembrane transport. Predicted to be located in Golgi apparatus; endoplasmic reticulum; and nucleoplasm. Predicted to be active in Golgi membrane. Human ortholog(s) of this gene implicated in congenital disorder of glycosylation type IIm. Orthologous to human SLC35A2 (solute carrier family 35 member A2). [provided by Alliance of Genome Resources, Jul 2025]

Details

Type
Protein Coding
Official Symbol
Slc35a2
Official Name
solute carrier family 35 member A2 [Source:RGD Symbol;Acc:2293497]
Ensembl ID
ENSRNOG00000024801
Bio databases IDs NCBI: 100158233 Ensembl: ENSRNOG00000024801
Aliases solute carrier family 35 member A2
Synonyms CDG2M, CDGX, Had-1, Sfc8, solute carrier family 35 member A2, Solute carrier family 35 (UDP-galactose transporter), member 2, solute carrier family 35 (UDP-galactose transporter), member A2, UDP-Gal-Tr, UGALT, UGAT, UGT, UGT1, UGT2, UGTL
Species
Rat, Rattus norvegicus
OrthologiesHumanMouse

Protein Domains

A protein domain is a distinct structural or functional region within a protein that can evolve, function, and exist independently of the rest of the protein chain. These domains in rat Slc35a2 often fold into stable, three-dimensional structures and are associated with specific biological functions, such as binding to DNA, other proteins, or small molecules.
  • UDP-galactose transporter
  • nucleotide-sugar transporter
  • EamA-like transporter family
  • enzyme
  • protein binding

Pathways

Biological processes and signaling networks where the Slc35a2 gene in rat plays a role, providing insight into its function and relevance in health or disease.

Top Findings

The most significant associations for this gene, including commonly observed domains, pathway involvement, and functional highlights based on current data.
disease
  • nonlesional localization related epilepsy
  • congenital disorder of glycosylation type 2m
  • congenital disorders of glycosylation
  • epilepsy
  • intoxication
  • X-linked complex neurodevelopmental disorder
  • hereditary disorder
  • focal cortical dysplasia type I
  • infection by HIV-1
  • infection by Enterovirus D68
regulated by
  • lipopolysaccharide
  • Immunoglobulin
  • PML
  • NFE2L2
  • FTO
  • tunicamycin
  • AHR/ARNT/aryl hydrocarbon
  • oltipraz
  • CAR/RXRα/CAR ligand/retinoic acid
  • EIF2AK3
regulates
  • bilirubin
  • SELE
  • UDP-D-galactose
  • UMP
  • CMP-sialic acid
  • Myelin
  • 1-naphthol
  • AMP
  • UDP-N-acetyl-D-galactosamine
  • galactosylceramide
role in cell
  • binding
  • phagocytosis
  • phagocytosis by
  • dipeptide repeat protein sensitivity

Subcellular Expression

Locations within the cell where the protein is known or predicted to be active, providing insight into its function and cellular context.
  • Cytoplasm
  • cellular membrane
  • Golgi Apparatus
  • Endoplasmic Reticulum
  • Golgi membrane
  • nucleoplasm

Gene Ontology Annotations

Describes the biological processes, cellular components, and molecular functions associated with the rat Slc35a2 gene, providing context for its role in the cell.

Biological Process

Functions and activities the gene product is involved in
  • UDP-galactose transmembrane transport
  • galactose metabolic process

Cellular Component

Where in the cell the gene product is active
  • endoplasmic reticulum membrane
  • endoplasmic reticulum
  • Golgi membrane
  • Golgi apparatus
  • nucleoplasm

Molecular Function

What the gene product does at the molecular level
  • UDP-galactose transmembrane transporter activity
  • protein binding
  • antiporter activity

Gene-Specific Assays for Results You Can Trust

Streamline your workflow with assays designed for this gene. Our targeted dPCR and qPCR assays help you generate meaningful data – efficiently and accurately.